Filing Details

Accession Number:
0000711377-11-000035
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-10-03 17:50:24
Reporting Period:
2011-09-29
Filing Date:
2011-10-03
Accepted Time:
2011-10-03 17:50:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1517426 J. Steven Quinlan 620 Lesher Place
Lansing MI 48912
Vice President & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-09-29 147 $34.38 647 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Option (Right to Buy) Acquisiton 2011-09-29 5,000 $0.00 5,000 $34.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2016-09-29 No 4 A Direct
Footnotes
  1. Shares acquired are held in the Neogen Corporation 401(k) Plan
  2. The options were granted September 29, 2011 and vest 20% yearly through September 29, 2016